ストックスクリーナーアプリを入手
12.21
3.74%
0.44
アフターアワーズ：
12.50
0.29
+2.38%
前日終値:
$11.77
開ける：
$11.85
24時間の取引高:
1.25M
Relative Volume:
2.09
時価総額：
$372.46M
収益：
$40.61M
当期純損益:
$-29.07M
株価収益率:
-12.11
EPS:
-1.0081
ネットキャッシュフロー:
$-26.70M
1週間 パフォーマンス:
-18.44%
1か月 パフォーマンス:
-19.35%
6か月 パフォーマンス:
+34.18%
1年 パフォーマンス:
-43.97%
1日の値動き範囲:
$11.54
$12.54
1週間の範囲:
$11.54
$15.42
52週間の値動き範囲:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
名前
Clearpoint Neuro Inc
セクター
電話
(949) 900-6833
住所
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
12.21 | 452.38M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2023-10-24 | 開始されました | Stifel | Buy |
| 2023-02-16 | 再開されました | B. Riley Securities | Buy |
| 2022-04-05 | 再開されました | B. Riley Securities | Buy |
| 2021-03-18 | 開始されました | Lake Street | Buy |
| 2020-07-17 | 開始されました | B. Riley FBR | Buy |
すべてを表示
Clearpoint Neuro Inc (CLPT) 最新ニュース
The Technical Signals Behind (CLPT) That Institutions Follow - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) Stock Price Today: $14.86 - Pluang
ClearPoint Neuro stock gains on recent momentum despite limited data - AD HOC NEWS
Stifel reiterates Clearpoint Neuro stock rating citing CGT focus - Investing.com
Stifel reiterates Clearpoint Neuro stock rating citing CGT focus By Investing.com - Investing.com Canada
Understanding the Setup: (CLPT) and Scalable Risk - Stock Traders Daily
ClearPoint Neuro stock slips as revenue misses estimates - AD HOC NEWS
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment - Yahoo Finance
ClearPoint Neuro Company Profile & Introduction - Moomoo
How (CLPT) Movements Inform Risk Allocation Models - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $25 - Moomoo
ClearPoint Neuro (CLPT) Retreats Nearly 4% as Shares Test Key Technical SupportHigh Beta Stocks - careplusvn.com
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - ACCESS Newswire
ClearPoint Neuro (CLPT) Q2 2026 Earnings: EPS Misses Estimates by Nearly 30%Weak Earnings Momentum - dars.gov.et
ClearPoint Neuro stock holds recent gains as earnings and analyst targets frame the next move - AD HOC NEWS
ClearPoint (CLPT) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Finish 11.80% Up on the DayEarnings Growth Analysis - dars.gov.et
ClearPoint (CLPT) Results at a Glance: The Bottom-Line Figure Trails Its Comparison in the Current Update; Trading Response: Shares Fall 2.01% at the CloseBuyback Announcement Report - vinanet.vn
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Conway Capital Management Inc. Makes New $1.66 Million Investment in ClearPoint Neuro, Inc. $CLPT - MarketBeat
ClearPoint Neuro (CLPT) Edges Lower as Shares Consolidate Between $14.57 Support and $16.11 ResistanceBullish Sentiment - vinanet.vn
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - AOL.com
(CLPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A - Stock Titan
ClearPoint Neuro (CLPT) Jumps 6.12% to $14.21: Key Levels to WatchRip Sell Trade - careplusvn.com
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - 富途牛牛
Clearpoint Neuro Inc (CLPT) Stock News Today - TradingKey
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
ClearPoint Neuro, Inc. (CLPT) Options Chain - Yahoo! Finance Canada
CLPT Looks 4.6% Overvalued on GF Value™ Ahead of Tuesday Market Drop - GuruFocus
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking Alpha
ClearPoint Neuro Updates Q2 Results and 2026 Outlook - The Globe and Mail
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Stifel cuts Clearpoint Neuro stock price target on guidance cut - Investing.com
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com South Africa
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks - Benzinga
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
How Does ClearPoint Neuro Inc (CLPT) Perform in Q2? EPS at -$0.3 - GuruFocus
Earnings call transcript: Clearpoint Neuro Q2 2026 misses estimates as shares fall - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
ClearPoint Neuro Q2 Earnings Call Highlights - Yahoo Finance
Clearpoint Neuro Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat
Transcript : ClearPoint Neuro, Inc., Q2 2026 Earnings Call, Aug 03, 2026 - marketscreener.com
ClearPoint Neuro (CLPT) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
ClearPoint Neuro, Inc. Updates Revenue Guidance for the Year 2026 - marketscreener.com
ClearPoint Neuro Q2 revenue rises 18% but misses estimates - TradingView
ClearPoint Neuro Reports Second Quarter 2026 Results - ACCESS Newswire
Clearpoint Neuro Inc (CLPT) 財務データ
収益
当期純利益
現金流量
EPS
Clearpoint Neuro Inc (CLPT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Option Exercise |
2.50 |
20,000 |
50,000 |
136,842 |
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Sale |
19.38 |
20,000 |
387,600 |
116,842 |
2.75%
大文字化:
|
ボリューム (24 時間):